Patel Chirag Ramanlal, Engineer Smita R, Shah Bharat J, Madhu S
Department of Anesthesia, B. J. Medical College, Civil Hospital, Ahmedabad, Gujarat, India.
Indian J Anaesth. 2012 Nov;56(6):542-6. doi: 10.4103/0019-5049.104571.
Dexmedetomidine, an α2 agonist, when used as an adjuvant in general anaesthesia attenuates stress response to various noxious stimuli, maintains perioperative haemodynamic stability and provides sedation without significant respiratory depression postoperatively.
Sixty patients were randomly divided into two groups of 30 each. In group A, fentanyl 2 μg/kg and in group B dexmedetomidine were given intravenously as loading dose of 1 μg/kg over 10 min prior to induction. After induction with thiopentone, in group B, dexmedetomidine was given as infusion at a dose of 0.2-0.8 μg/kg. Sevoflurane was used as inhalation agent in both groups. Haemodynamic variables and entropy (response entropy and state entropy) were recorded continuously. Postoperative sedation and recovery were assessed by sedation score and modified Aldrete's score, respectively.
Dexmedetomidine significantly attenuates stress response at intubation with lesser increase in heart rate (10% vs. 17%), systolic blood pressure (6% vs. 23%) and diastolic blood pressure (7% vs. 20%) as compared to the control group (P<0.05). Intraoperatively, an average of 8% fall in systolic blood pressure and 8.16% fall in diastolic pressure in the test group as compared to 3.6% rise in systolic and 3.3% in diastolic pressure of the control group was observed. Postoperatively, the test group showed significant sedation at 2 h as compared to the control group (P=0.00) and recovery was better in the control group for the first 2 h post extubation.
Dexmedetomidine attenuates various stress responses during surgery and maintains the haemodynamic stability when used as an adjuvant in general anaesthesia. Also, the sedative action of dexmedetomidine delays recovery for the first few hours post extubation.
右美托咪定是一种α2激动剂,在全身麻醉中用作辅助药物时,可减轻对各种有害刺激的应激反应,维持围手术期血流动力学稳定,并提供镇静作用,且术后无明显呼吸抑制。
60例患者随机分为两组,每组30例。A组静脉注射芬太尼2μg/kg,B组在诱导前10分钟静脉注射右美托咪定1μg/kg作为负荷剂量。硫喷妥钠诱导后,B组以0.2 - 0.8μg/kg的剂量输注右美托咪定。两组均使用七氟醚作为吸入麻醉剂。连续记录血流动力学变量和熵(反应熵和状态熵)。分别通过镇静评分和改良的Aldrete评分评估术后镇静和恢复情况。
与对照组相比,右美托咪定在插管时显著减轻应激反应,心率升高幅度较小(10%对17%)、收缩压升高幅度较小(6%对23%)和舒张压升高幅度较小(7%对20%)(P<0.05)。术中,试验组收缩压平均下降8%,舒张压下降8.16%,而对照组收缩压升高3.6%,舒张压升高3.3%。术后,试验组在2小时时与对照组相比有显著镇静作用(P = 0.00),拔管后前2小时对照组恢复情况更好。
右美托咪定在全身麻醉中用作辅助药物时,可减轻手术期间的各种应激反应并维持血流动力学稳定。此外,右美托咪定的镇静作用会使拔管后最初几个小时的恢复延迟。